Neoadjuvant immunotherapy for melanoma is now ready for clinical practice.

Details

Request a copyRequest a copy
Serval ID
serval:BIB_079BED918172
Type
Article: article from journal or magazin.
Publication sub-type
Letter (letter): Communication to the publisher.
Collection
Publications
Institution
UNIL/CHUV
Title
Neoadjuvant immunotherapy for melanoma is now ready for clinical practice.
Journal
Nature medicine
Author(s)
Garbe C., Dummer R., Amaral T., Amaria R.N., Ascierto P.A., Burton E.M., Dreno B., Eggermont AMM, Hauschild A., Hoeller C., Kaufmann R., Lebbe C., Mandala M., Menzies A.M., Moreno D., Michielin O., Nathan P., Patel S.P., Robert C., Schadendorf D., Lorigan P.C., Scolyer R.A., Tawbi H.A., van de Wiel B.A., Blank C., Long G.V.
ISSN
1546-170X (Electronic)
ISSN-L
1078-8956
Publication state
Published
Issued date
06/2023
Peer-reviewed
Oui
Volume
29
Number
6
Pages
1310-1312
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Keywords
Humans, Neoadjuvant Therapy, Melanoma/drug therapy, Skin Neoplasms/drug therapy, Immunotherapy
OAI-PMH
oai:serval.unil.ch:BIB_079BED918172
DOI
10.1038/s41591-023-02336-1
Pubmed
37193799
Web of science
000988452900001
Create date
23/05/2023 13:21
Last modification date
09/12/2023 7:04
Usage data